| Doramectin |
多拉菌素 |
117704-25-3 |
| Dapoxetine |
达泊西汀 |
119356-77-3 |
| N-[3-([4,5'-bipyriMidin]-2-ylaMino)-4-Methylphenyl]-4-[[(3S)-3-(diMethylaMino)-1-pyrrolidinyl]Methyl]-3-(trifluoroMethyl)-benzaMide, (HCl salt) |
N-[3-([4,5'-bipyriMidin]-2-ylaMino)-4-Methylphenyl]-4-[[(3S)-3-(diMethylaMino)-1-pyrrolidinyl]Methyl]-3-(trifluoroMethyl)-benzaMide, (HCl salt) |
859212-17-2 |
| ADX-47273 |
(S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基}甲酮 |
851881-60-2 |
| 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
| Pictilisib |
GDC-0941 |
957054-30-7 |
| PD04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
| 2-allyl-6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one |
2-烯丙基-6-(甲基硫代)-1H-吡唑并[3,4-D]嘧啶-3(2H)-酮 |
955368-90-8 |
| ARN-509 |
阿帕鲁胺 |
956104-40-8 |
| 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide |
4-[(二乙基氨基)甲基]-N-[2-(2-甲氧基苯基)乙基]-N-(3R)-3-吡咯烷基苯甲酰胺 |
947303-87-9 |
| RO5068760 |
RO5068760 |
947182-25-4 |
| BNC105P |
[6-甲氧基-2-甲基-7-(磷酰氧基)-3-苯并呋喃基](3,4,5-三甲氧基苯基)甲酮钠盐 |
945771-96-0 |
| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| Tie2 kinase inhibitor |
Tie2 kinase inhibitor |
948557-43-5 |
| KU-0063794 |
KU-0063794 |
938440-64-3 |
| D-106669 |
N-乙基-N'-[3-[(4-甲基苯基)氨基]吡啶并[2,3-B]吡嗪-6-基]脲 |
938444-93-0 |
| 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 |
937174-76-0 |
| ARRY-380 |
ARRY-380 |
937265-83-3 |
| Lumacaftor (VX-809) |
鲁玛卡托 |
936727-05-8 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
